Ecolab Inc. ECL · NYSE
$291.75 +0.32% (+$0.94)
Summary
70 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 24% a year over the last 3 years.
- Out of every 100 USD of revenue, 13 USD is left as net profit.
- It has raised its dividend 21 years in a row and pays out only 39% of profit.
- It earns 9.4 USD a year on every 100 USD of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 38.5 USD for 1 USD of yearly profit. Over the last five years it was 41.5 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 6.4% a year over 5 years. Over the last 3 years it grew by 4.3% a year. For the next fiscal year analysts expect revenue to grow by 11%. Earnings per share grew by 24% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 56 USD
- Sales and administration 27 USD
- Taxes and other 4.8 USD
- Net profit 13 USD
Net profit, industry median (Chemicals - Specialty) 6.1 USD
Out of every 100 USD of revenue, 13 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.3 years of free cash flow. Its debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.00%
- Paid out of profit
- 39%
- Raised in a row
- 21 years
You receive $2.92 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 29
- Hold 7
- Sell 1
Today's price within the analysts' price targets
The average target of $326.38 is 12% above today's price. 78% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Global Water 50%
- Global Institutional and Specialty 38%
- Global Pest Elimination 7.8%
- Global Life Sciences 4.7%
By region
- UNITED STATES 53%
- Europe 20%
- Asia Pacific 8.5%
- Latin America 6.8%
- C [N] 4.5%
- Other 7.1%
Global Water brings in 50% of revenue. Global Institutional and Specialty grew fastest, by 11% a year.
Segments in detail